A Study of MT027 in Patients with Pleural Malignant Tumors

NCT06726564 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumor
Malignant Pleural Effusion
Pleura Carcinoma
Pleural Mesothelioma
Pleural Malignant Mesothelioma
Pleural Metastases

Interventions

DRUG: MT027 cells suspension

Sponsor

Suzhou Maximum Bio-tech Co., Ltd.

Collaborators

[object Object]